Takeda has bought a licence for a coeliac disease drug from COUR Pharmaceuticals, after the US biotech announced supportive phase 2a trial data. Gastrointestinal diseases are one of the Japanese ...
Studio Pierrot has unveiled the first teaser trailer and key visual for the final part of the Bleach anime, Thousand-Year Blood War (TYBW) Cour 4, confirming its release in July 2026. This last ...
Bleach: Thousand-Year Blood War cour 4 has finally cleared up one of the biggest uncertainties in the fandom over the past few months. New reports confirm how many episodes would be part of the final ...
US biotech COUR Pharma has closed a $50 million series B financing round to advance CNP-103, its experimental type 1 diabetes therapy designed to address the autoimmune cause of the disease rather ...
CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The main trailer for Dr. Stone: Science Future Cour 3 has been released ahead of its April 2 premiere, featuring a new visual, character Sai and opening theme by Asian Kung-Fu Generation. A brand-new ...
The Jump Festa 2026 panel for Bleach, which was held on Dec. 21, 2025, revealed that Bleach: Thousand-Year Blood War arc’s final cour, titled The Calamity (Kashintan), will release on July 2026. The ...
Bleach TYBW Cour 4 will end everything that started decades ago, with the final battle between Quincy and the Soul Reapers. Jump Festa 2026 has showcased the teaser PV for the final chapter, featuring ...
Dr. Stone: Science Future Cour 3 is set to release in 2026. The announcement was made after the final episode of the second cour premiered in Japan. An announcement visual featuring Senku was also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results